C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor

Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2004
11/03/2004	EP1473368A1 Alpha-substituted-alpha, beta-unsaturated carbonyl compound reductase gene
11/03/2004	EP1473367A1 Means and methods for diagnosing and treating affective disorders
11/03/2004	EP1473366A1 Keratinocyte growth factor-2 products
11/03/2004	EP1473365A1 Angiogenesis inhibitors
11/03/2004	EP1473364A1 Method of testing food
11/03/2004	EP1473363A1 Method of monitoring gene expression
11/03/2004	EP1473362A1 Glycosylation variants of BACE
11/03/2004	EP1473361A2 Genetically engineered attenuated viruses
11/03/2004	EP1473360A2 Methods for the ex-vivo replication and stable genetic transformation of human stem cells
11/03/2004	EP1473307A1 Method for modifying the size and/or morphology of starch granules
11/03/2004	EP1473305A1 Novel glutamate receptor and utilization thereof
11/03/2004	EP1473304A1 Method for preparation of a N-terminally modified chemotactic factor
11/03/2004	EP1473303A1 Novel proteins and dnas thereof
11/03/2004	EP1473299A2 Isolation of nucleid acids
11/03/2004	EP1473039A1 Use of inhibitors and antisense oligonucleotides of BTK for the treatment of proliferative mastocytosis
11/03/2004	EP1473038A1 Method of protecting living body from foreign factor and composition therefor
11/03/2004	EP1472544A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/03/2004	EP1472543A2 Methods and compositions involving the hsp 90 activator aha1
11/03/2004	EP1472540A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908
11/03/2004	EP1472538A2 Device for performing cell assays
11/03/2004	EP1472518A2 Automatic threshold setting and baseline determination for real-time pcr
11/03/2004	EP1472515A2 MINRs AS MODIFIERS FO INSULIN RECEPTOR SIGNALING AND METHODS OF USE
11/03/2004	EP1472379A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
11/03/2004	EP1472378A2 Genetic markers for the diagnosis of the expression of inverted nipples in pets, breeding animals and domestic cattle
11/03/2004	EP1472377A2 Genetic polymorphisms in the preprotachykinin gene
11/03/2004	EP1472376A2 Methods and compositions for treating urological disorders using 1435, 559, 34021, 44099, 25278, 641, 260, 55089, 21407, 42032, 46656, 62553, 302, 323, 12303, 985, 13237, 13601, 18926, 318, 2058 or 6351 mo
11/03/2004	EP1472375A1 Gene products differentially expressed in cancerous breast cells and their methods of use
11/03/2004	EP1472374A2 Eif4e gene mutations and potyvirus resistance
11/03/2004	EP1472373A2 Methods for making polynucleotides and purifying double-stranded polynucleotides
11/03/2004	EP1472370A1 Methods for specific rapid detection of pathogenic food-relevant bacteria
11/03/2004	EP1472369A2 Quantitative methylation detection in dna samples
11/03/2004	EP1472366A2 Verification of food origin based on nucleic acid pattern recognition
11/03/2004	EP1472365A2 Receptor capture assay
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472360A1 Method for producing methacrylic acid and acrylic acid with a combination of enzyme catalysts
11/03/2004	EP1472359A2 Egvii endoglucanase and nucleic acids encoding the same
11/03/2004	EP1472358A2 Non-linear amplitude dielectrophoresis waveform for cell fusion
11/03/2004	EP1472357A2 Elongase gene and method for producing polyunsaturated fatty acids
11/03/2004	EP1472356A2 Plant growth modulation by drl1 and other proteins of the elongator complex
11/03/2004	EP1472355A1 Method for the production of zymosterol and/or the biosynthetic intermediate and/or subsequent products thereof in transgenic organisms
11/03/2004	EP1472353A2 Group b streptococcus antigen
11/03/2004	EP1472352A2 Novel compounds
11/03/2004	EP1472350A1 Compositions and methods for identifying transformed cells
11/03/2004	EP1472349A1 Methods for multiple parameter screening and evolution of cells to produce small molecules with multiple functionalities
11/03/2004	EP1472348A2 Light activated gene transduction using ultraviolet light for cell targeted gene delivery
11/03/2004	EP1472347A2 Improved protein expression in bacillus subtilis
11/03/2004	EP1472344A2 Novel protein
11/03/2004	EP1472342A2 Oxa1p enhanced protein secretion
11/03/2004	EP1472339A1 A process for identifying a novel target for use for the development of therapeutic modalities and drugs effective against tuberculosis
11/03/2004	EP1472338A2 Modulation of sulfate permease for photosynthetic hydrogen production
11/03/2004	EP1472286A1 Production process of recombinant placental growth factor
11/03/2004	EP1472285A2 Secretory molecules
11/03/2004	EP1472283A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/03/2004	EP1472281A1 Gene conferring resistance to phytophthera infestans (late-blight) in solanaceae
11/03/2004	EP1472274A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1472269A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2004	EP1472267A2 Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1472265A2 Rna interference mediated inhibition of polycomb group protein ezh2 gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1471938A2 Human monoclonal antibodies against cd30
11/03/2004	EP1471937A1 A continuous cell line for the production of vaccines
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471931A2 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471926A2 Compositions and methods for the therapeutic use of an atonal-associated sequence
11/03/2004	EP1471922A2 METHODS AND MATERIALS FOR MODULATING TASK−3
11/03/2004	EP1471873A2 Flavivirus vaccines
11/03/2004	EP1471819A2 Composition and imaging methods for pharmacokinetic and pharmacodynamic evaluation of therapeutic delivery system
11/03/2004	EP1471818A2 Methods and compositions for treating hematological disorders using 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137, 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 or 13249 molecules
11/03/2004	EP1434871A4 Selection of cells expressing heteromeric polypeptides
11/03/2004	EP1383901B1 Circuit arrangement for injecting nucleic acids and other biologically active molecules into the nucleus of higher eucaryontic cells using electrical current
11/03/2004	EP1311706A4 A method of detecting microorganisms
11/03/2004	EP1268508A4 Quality control reagents for nucleic acid microarrays
11/03/2004	EP1220950B9 Genetic markers of toxicity, preparation and uses thereof
11/03/2004	EP1204746B1 Sentrin-specific human protease senp1
11/03/2004	EP1181559B8 System and method for filling a substrate with a liquid sample
11/03/2004	EP1181389A4 Method of amplification of nucleic acids
11/03/2004	EP1100965A4 Method of and composite for fluorescent in situ hybridization
11/03/2004	EP1017855B1 Methods of synthesizing polynucleotides by ligation of multiple oligomers
11/03/2004	EP1009807A4 DIFFERENTIAL LIGAND ACTIVATION OF ESTROGEN RECEPTORS ER$g(a) AND ER$g(b) AT AP1 SITES
11/03/2004	EP1002126A4 Improved method for isolating and recovering target dna or rna molecules having a desired nucleotide sequence
11/03/2004	EP0973885B1 Disassociation of interacting molecules
11/03/2004	EP0929669B1 Antigens derived from filaggrin and their use for diagnosing rheumatoid polyarthritis
11/03/2004	EP0928332B1 Process for developing mammals with definite genetic features
11/03/2004	EP0927249B1 E2f ubiquitination domain, and assays for inhibitors of e2f ubiquitination
11/03/2004	EP0896625B1 Recombinant ribonuclease proteins
11/03/2004	EP0789708B1 Multifunctional molecular complexes for gene transfer to cells
11/03/2004	EP0769556B1 Gene coding for a heat stable beta-amylase from barley
11/03/2004	EP0729325B1 Osteogenic product and use
11/03/2004	EP0705338B1 Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s)
11/03/2004	EP0698216B1 Methods of typing hepatitis c virus and reagents for use therein
11/03/2004	EP0698101B1 Hepatitis-c virus type 4, 5 and 6
11/03/2004	EP0694042B1 Inhibitor of vascular endothelial cell growth factor
11/03/2004	EP0594843B1 Antibody assay for amylin
11/03/2004	CN1543570A Identifying compounds that modulate interaction of neuronal nitric oxide synthase and its inhibitor, useful e.g. for treating prediabetic states
11/03/2004	CN1543510A Zinc finger domain libraries
11/03/2004	CN1543508A Test systems and the use thereof for identifying and characterizing compounds
11/03/2004	CN1543506A Novel targets for herbicides and transgenic plants resistant to said herbicides
11/03/2004	CN1543505A Novel amylases and uses thereof

1 ... 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 2164 ... 4023